Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (vol 19, pg 83, 2019)

Colaboración

Año: 2019

Canet, LM; Sanchez-Maldonado, JM; Caliz, R; Rodriguez-Ramos, A; Lupianez, CB; Canhao, H; Martinez-Bueno, M; Escudero, A; Segura-Catena, J; Sorensen, SB; Hetland, ML; Soto-Pino, MJ; Ferrer, MA; Garcia, A; Glintborg, B; Filipescu, I; Perez-Pampin, E; Gonzalez-Utrilla, A; Nevot, MAL; Conesa-Zamora, P; den Broeder, A; De Vita, S; Jacobsen, SEH; Collantes-Estevez, E; Quartuccio, L; Canzian, F; Fonseca, JE; Coenen, MJH; Andersen, V; Sainz, J

Título: PHARMACOGENOMICS JOURNAL

• Q2